Eli Lilly and Co
XHAM:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XHAM:LLY
|
US |
|
Novartis AG
LSE:0QLR
|
CH |
|
3i Group PLC
F:IGQ
|
UK |
|
A
|
American Water Works Company Inc
F:AWC
|
US |
|
S
|
SITC International Holdings Co Ltd
XBER:7S8
|
HK |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 096.72 EUR with a low forecast of 764.4 EUR and a high forecast of 1 402.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 096.72
EUR
According to Wall Street analysts, the average 1-year price target for LLY is 1 096.72 EUR with a low forecast of 764.4 EUR and a high forecast of 1 402.36 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 20%.
What is the Gross Profit forecast for Eli Lilly and Co?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 24%.
What is the Pre-Tax Income forecast for Eli Lilly and Co?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 31%.
